11 мая 2021 г. · To compare the efficacy and safety between aspirin versus clopidogrel monotherapy as chronic maintenance therapy in patients who received PCI ...

The HOST-EXAM trial reported superiority of Clopidogrel over Aspirin monotherapy during a 2- year follow-up in stable CAD pts who were event-free under DAPT for ...

7 нояб. 2022 г. · The HOST-EXAM Extended study supports clopidogrel as the preferable antiplatelet agent prescribed for secondary prevention of coronary artery disease.

16 мая 2021 г. · The HOST-EXAM is the first randomised trial to compare clopidogrel and aspirin monotherapy in patients who received percutaneous coronary ...

17 апр. 2023 г. · The HOST-EXAM trial showed that clopidogrel monotherapy is superior to aspirin monotherapy as chronic maintenance therapy among patients.

The HOST-EXAM trial is planning to continue follow-up until year 2025. No individual participant data will be available prior to this. Any relevant inquiry ...

22 окт. 2024 г. · The HOST-EXAM Extended study reports the post-trial follow-up results of the original HOST-EXAM trial. Methods: From March 2014 through May ...

22 окт. 2024 г. · Conclusions: The HOST-EXAM will be the first large-scale randomized controlled study to directly compare the efficacy and safety of long-term ...

22 сент. 2023 г. · The HOST-EXAM Extended study reported the benefit of clopidogrel monotherapy over aspirin monotherapy in secondary prevention after ...

26 июн. 2021 г. · Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, ...